Literature DB >> 24203848

2013 Thomas Willis Award Lecture: Causation and collaboration for stroke research.

Eng H Lo1.   

Abstract

The pathophysiology of stroke is complex. Adaptive and maladaptive signalling occurs between multiple cell types in the brain. There is crosstalk between central and systemic responses. And there are overlapping pathways during initial injury and subsequent repair. These numerous feed-forward and feed-back interactions have made it difficult to translate experimental discoveries into clinical applications. An emerging hypothesis in biomedical research now suggests that contrary to a traditional model, translation may not be efficiently obtained without a rigorous understanding of mechanisms. Hence, to optimize diagnostics and therapeutics for stroke patients, it is necessary to identify and define causal mechanisms. Mirroring the multi-compartment interactions in stroke pathophysiology, bench-to-bedside, and bedside-back-to-bench advances in stroke may be best achieved with inter-disciplinary collaborations between basic research, neuroimaging, and broadly based clinical science. Causation can then be two-fold, ie, dissecting mechanisms and targets, as well as developing future scientists who can blur the boundaries between basic, translational, and clinical research. In systems theory, a critical goal is to distinguish causation from correlation. In stroke research, causation may perhaps be found through a collaborative search for mechanisms.

Entities:  

Keywords:  brain injuries; cerebrovascular disorders; translational research

Mesh:

Year:  2013        PMID: 24203848      PMCID: PMC4067238          DOI: 10.1161/STROKEAHA.113.001269

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  44 in total

1.  Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy.

Authors:  Xiang Fan; Zhanyang Yu; Jianxiang Liu; Ning Liu; Katherine A Hajjar; Karen L Furie; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 2.  Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic.

Authors:  Zheng Gang Zhang; Michael Chopp
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

3.  Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery.

Authors:  Muge Yemisci; Yasemin Gursoy-Ozdemir; Atay Vural; Alp Can; Kamil Topalkara; Turgay Dalkara
Journal:  Nat Med       Date:  2009-08-30       Impact factor: 53.440

Review 4.  The science of stroke: mechanisms in search of treatments.

Authors:  Michael A Moskowitz; Eng H Lo; Costantino Iadecola
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

5.  Degeneration and repair in central nervous system disease.

Authors:  Eng H Lo
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

Review 6.  Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.

Authors:  David C Hess; Susan C Fagan
Journal:  Pharmacotherapy       Date:  2010-07       Impact factor: 4.705

Review 7.  Advanced CT imaging in the evaluation of hemorrhagic stroke.

Authors:  Josser E Delgado Almandoz; Javier M Romero
Journal:  Neuroimaging Clin N Am       Date:  2011-05       Impact factor: 2.264

8.  Proteomic temporal profile of human brain endothelium after oxidative stress.

Authors:  Mingming Ning; David A Sarracino; Alvin T Kho; Shuzhen Guo; Sun-Ryung Lee; Bryan Krastins; Ferdinando S Buonanno; Juan A Vizcaíno; Sandra Orchard; David McMullin; Xiaoying Wang; Eng H Lo
Journal:  Stroke       Date:  2010-12-16       Impact factor: 7.914

9.  Domain architecture evolution of pattern-recognition receptors.

Authors:  Qing Zhang; Christian M Zmasek; Adam Godzik
Journal:  Immunogenetics       Date:  2010-03-02       Impact factor: 2.846

10.  Generation of transgenic non-human primates with germline transmission.

Authors:  Erika Sasaki; Hiroshi Suemizu; Akiko Shimada; Kisaburo Hanazawa; Ryo Oiwa; Michiko Kamioka; Ikuo Tomioka; Yusuke Sotomaru; Reiko Hirakawa; Tomoo Eto; Seiji Shiozawa; Takuji Maeda; Mamoru Ito; Ryoji Ito; Chika Kito; Chie Yagihashi; Kenji Kawai; Hiroyuki Miyoshi; Yoshikuni Tanioka; Norikazu Tamaoki; Sonoko Habu; Hideyuki Okano; Tatsuji Nomura
Journal:  Nature       Date:  2009-05-28       Impact factor: 49.962

View more
  7 in total

1.  Translational intracerebral hemorrhage: a need for transparent descriptions of fresh tissue sampling and preclinical model quality.

Authors:  Che-Feng Chang; Li Cai; Jian Wang
Journal:  Transl Stroke Res       Date:  2015-04-25       Impact factor: 6.829

2.  Comparative transcriptome of neurons after oxygen-glucose deprivation: Potential differences in neuroprotection versus reperfusion.

Authors:  Shuzhen Guo; Anna Tjärnlund-Wolf; Wenjun Deng; Emiri Tejima-Mandeville; Lauren J Lo; Changhong Xing; Ken Arai; MingMing Ning; Yiming Zhou; Eng H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-28       Impact factor: 6.200

3.  Differential subnetwork of chemokines/cytokines in human, mouse, and rat brain cells after oxygen-glucose deprivation.

Authors:  Yang Du; Wenjun Deng; Zixing Wang; MingMing Ning; Wei Zhang; Yiming Zhou; Eng H Lo; Changhong Xing
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  Opening a New Time Window for Treatment of Stroke by Targeting HDAC2.

Authors:  Yu-Hui Lin; Jian Dong; Ying Tang; Huan-Yu Ni; Yu Zhang; Ping Su; Hai-Ying Liang; Meng-Cheng Yao; Hong-Jin Yuan; Dong-Liang Wang; Lei Chang; Hai-Yin Wu; Chun-Xia Luo; Dong-Ya Zhu
Journal:  J Neurosci       Date:  2017-06-07       Impact factor: 6.167

5.  Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal.

Authors:  Athanasios Lourbopoulos; Iordanis Mourouzis; Christodoulos Xinaris; Nefeli Zerva; Konstantinos Filippakis; Angelos Pavlopoulos; Constantinos Pantos
Journal:  Front Neurosci       Date:  2021-05-14       Impact factor: 4.677

6.  Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease.

Authors:  Hiroto Takahashi; Peng Xia; Jiankun Cui; Maria Talantova; Karthik Bodhinathan; Wenjun Li; Sofiyan Saleem; Emily A Holland; Gary Tong; Juan Piña-Crespo; Dongxian Zhang; Nobuki Nakanishi; James W Larrick; Scott R McKercher; Tomohiro Nakamura; Yuqiang Wang; Stuart A Lipton
Journal:  Sci Rep       Date:  2015-10-19       Impact factor: 4.379

7.  GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Attenuates Cerebral Ischemia Injury In Vivo and Vitro by Differential Modulations of NMDA Receptors Subunit Components at Different Post-Ischemia Stage in Mice.

Authors:  Chen Zheng; Zhi H Qiao; Meng Z Hou; Nan N Liu; Bin Fu; Ran Ding; Yuan Y Li; Liang P Wei; Ai L Liu; Hui Shen
Journal:  Front Aging Neurosci       Date:  2017-06-09       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.